Target intelligence / Profile preview

Dickkopf-related protein 1 (DKK1)

Target
DKK1
Molecular classification
Secreted glycoprotein, Dickkopf (DKK) family member
01

Overview

Dickkopf-related protein 1 (DKK1) is a secreted glycoprotein that acts as an antagonist of the Wnt/β-catenin signaling pathway. It inhibits Wnt signaling by binding to LRP5/6 co-receptors, preventing downstream activation. DKK1 plays critical roles in embryonic development, bone homeostasis, and is implicated in various diseases including cancer, bone disorders, and cardiovascular disease. It is being investigated as a therapeutic target, particularly in oncology and immunotherapy, with anti-DKK1 antibodies showing promise in preclinical studies.

02

Mechanism of action

DKK1 binds to LRP5/6 co-receptors, preventing activation of downstream Wnt signaling events. Anti-DKK1 antibodies neutralize DKK1, promoting Wnt signaling and potentially reducing immune suppression.

03

Biological functions

Wnt/β-catenin signaling pathway antagonistEmbryonic developmentBone homeostasisRegulation of PAI-1 expressionImmunomodulation
04

Disease associations

CancerBone disordersCardiovascular diseaseRheumatoid arthritis
05

Safety considerations

Potential disruption of Wnt signaling in normal tissuesImmunogenicity of antibody-based therapies
06

Interacting drugs

Anti-DKK1 antibodies (e.g., DKN-01)
07

Biomarkers

Elevated DKK1 levels in cancer (prostate, pancreatic)Elevated DKK1 levels in multiple myeloma

Beyond the preview

Go deeper on Dickkopf-related protein 1 (DKK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dickkopf-related protein 1 (DKK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call